TL;DR: Modulari-T is a Y Combinator Winter 2023 startup We teach your immune system to attack and cure cancer, currently active with a team of 4.
We teach your immune system to attack and cure cancer
Last verified:
Cell and gene therapy promises to one day cure any disease; Modulari-T’s Platform produces the tools to fulfill that promise. Modulari-T has designed a new family of synthetic genes that can reprogram cells to better sense their environment and modify their behavior accordingly. This can be used to engineer immune cells to efficiently recognize and kill cancer cells or to create stem cells able to regenerate any tissue. Modulari-T looks to expand its technology to reach every area of cell therapy and become the platform of reference for cell engineering.
Built by LemStudio
Yes. Modulari-T was funded by Y Combinator in the Winter 2023 batch. We teach your immune system to attack and cure cancer
Cell and gene therapy promises to one day cure any disease; Modulari-T’s Platform produces the tools to fulfill that promise. Modulari-T has designed a new family of synthetic genes that can reprogram cells to better sense their environment and modify their behavior accordingly. This can be used to engineer immune cel…
Modulari-T was part of Y Combinator's Winter 2023 batch.
Modulari-T has a team of 4 people according to Y Combinator's directory.
Modulari-T is currently listed as Active with a team of 4 in Y Combinator's directory.
Loading interactive view…